Matthew Etmanczyk serves as a Senior Business Development Director at Labcorp Drug Development, where he plays a pivotal role in bridging the gap between innovative biotech companies and comprehensive clinical solutions. With a focus on Small Biotech, Emerging Biotech, Mid/Large Pharma, and consulting firms across...
Matthew Etmanczyk serves as a Senior Business Development Director at Labcorp Drug Development, where he plays a pivotal role in bridging the gap between innovative biotech companies and comprehensive clinical solutions. With a focus on Small Biotech, Emerging Biotech, Mid/Large Pharma, and consulting firms across the United States, Matthew leverages his extensive expertise in drug discovery and clinical development to tailor industry solutions that meet the unique needs of his clients.
In his current role, Matthew is instrumental in expanding Labcorp's presence in the Midwest and Northwest Pacific regions, particularly within the Clinical Pharmacology sector. He is adept at establishing and nurturing relationships with key stakeholders, ensuring that clients receive personalized support throughout their drug development journey. His strategic approach includes developing detailed account plans and fostering partnerships that drive mutual growth and success.
Matthew's deep understanding of the biopharmaceutical landscape, combined with his skills in Good Laboratory Practice (GLP), toxicology, and regulatory compliance with the U.S. Food and Drug Administration (FDA), positions him as a trusted advisor in the industry. He is particularly focused on facilitating a range of Clinical Pharmacology trials, including Single Ascending Dose and Multiple Ascending Dose studies, which are critical for advancing drug candidates through the development pipeline. By providing tailored solutions and insights, Matthew not only enhances Labcorp's service offerings but also empowers his clients to navigate the complexities of drug development with confidence.
